Practice
Featured experience
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Durational Capital Management strategic investment in Garage Beer
We are advising Durational Capital Management on the transaction
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Orogen Group acquisition of a majority interest in Westcor Land Title Insurance
Davis Polk is advising The Orogen Group on its acquisition of a majority interest in Westcor Land Title Insurance Company…
Spirit Airlines $850 million senior notes offering
Davis Polk advised Spirit Airlines, Inc. in connection with a Rule 144A/Regulation S offering of $850 million aggregate…
Sterling Equities sale of the New York Mets
We advised Sterling Equities on the sale
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The…
Emerson $1.6 billion acquisition of Open Systems International
Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc.
Emerson,…
American Well strategic partnership with Google Cloud
Davis Polk is advising Amwell on its agreement to form a multi-year, strategic partnership with Google Cloud to deliver…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…
CureVac $245.3 million IPO
Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which…
Roper Technologies $5.35 billion acquisition of Vertafore
Davis Polk is advising Roper Technologies, Inc. in connection with its $5.35 billion acquisition of Vertafore, a portfolio…
Freeline Therapeutics Holdings $158.8 million IPO
Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American…